Skip to Main Content
Contribute Try STAT+ Today

The trial of Elizabeth Holmes resulted in a mixed verdict, but one outcome is clear: This was a big victory for prosecutors in a high-profile case where the defendant now faces a lengthy prison sentence.

Holmes’ conviction on four fraud charges involving huge sums of money invested in Theranos, the now-shuttered blood testing startup with Holmes at the helm, means she will likely spend many years behind bars. The three wire fraud counts accounted for more than $144 million in investments, a sum that will significantly drive up the length of her sentence, legal experts said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment